| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/08/2008 | WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative |
| 05/08/2008 | WO2008053517A1 Agent for promoting in vivo dha synthesis and seaweed oil |
| 05/08/2008 | WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008052734A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | WO2008052679A2 Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis |
| 05/08/2008 | WO2008052671A2 Combination therapy of substituted oxazolidinones |
| 05/08/2008 | WO2008052431A1 Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder |
| 05/08/2008 | WO2008052417A1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof |
| 05/08/2008 | WO2008052410A1 A supermolecule composition of water-soluble coenzyme q10 and preparation method thereof |
| 05/08/2008 | WO2008052295A1 Process for the preparation of compounds of at1 receptor antagonists with angiotensin-(1-7), analogues thereof and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products |
| 05/08/2008 | WO2008002591A3 Methods for treating atherosclerosis |
| 05/08/2008 | WO2007147889A3 Preparation of telmisartan salts |
| 05/08/2008 | US20080108703 Methods for Improving Bioavailability of a Renin Inhibitor |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108687 Ramipril formulation |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108656 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/08/2008 | US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108638 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 05/08/2008 | US20080108635 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 05/08/2008 | US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108611 Substituted thienopyrimidine kinase inhibitors |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108589 Method of treatment with coadministration of aspirin and prasugrel |
| 05/08/2008 | US20080108575 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 05/08/2008 | US20080108573 Compositions And Methods For Treatment Of Cardiovascular Disease |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108550 Hdl for the treatment of stroke and other ischemic conditions |
| 05/08/2008 | US20080107759 Bamboo of Sasa genus or Phyllostachys genus; extracted with water, alcohol, non-polar hexane, ethyl acetate, chloroform and dichloromethane |
| 05/08/2008 | US20080107741 Angiogenesis inhibitor particles having a particle size of less than 2000 nm; and associated with the surface thereof at least one surface stabilizer |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107621 Use Of Il - 6 In Microvascular Complicaitions |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | DE102006051796A1 Triaza-benzo[e]azulenderivate Triaza-benzo [e] azulene derivatives |
| 05/08/2008 | CA2668330A1 Mixed cell populations for tissue repair and separation technique for cell processing |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2667962A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | CA2667759A1 Use of nutritional compositions for preventing disorders |
| 05/08/2008 | CA2667664A1 Use of a fusion protein targeting the ed-b fibronectin domain for treatment of atherosclerosis |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918300A2 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1918000A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| 05/07/2008 | EP1917980A1 Use of a fusion protein between a cytokine and an antibody targeting the ED-B fibronectin domain for the treatment of atherosclerosis |
| 05/07/2008 | EP1917979A1 Therapeutic agent for atrial fibrillation |
| 05/07/2008 | EP1917977A1 Therapeutic drug for heart disease and virus disease |
| 05/07/2008 | EP1917010A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 05/07/2008 | EP1917008A2 Use of soluble guanylate cyclase for the treatment of raynaud's phenomenon |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1372688B1 Somatostatin antagonists |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | EP1339409B1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 05/07/2008 | EP1284957B1 Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | CN101175758A Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 05/07/2008 | CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 05/07/2008 | CN101175490A Agent for improving circulatory disorder |
| 05/07/2008 | CN101175416A A method and composition for nutritionally improving glucose control and insulin action |
| 05/07/2008 | CN101173301A Construction method for pacemaking channels gene hypotype HCN4 recombined retroviral vector |
| 05/07/2008 | CN101173281A Rhabdophis tigrinus uncoupling protein gene -SA and uses thereof |
| 05/07/2008 | CN101172997A Oligopeptide or its modified compound/derivant and application thereof |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172977A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 05/07/2008 | CN101172971A Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof |
| 05/07/2008 | CN101172155A Novel dosage forms of pulse-activating gallbladder warming soup and method of preparing the same |
| 05/07/2008 | CN101172147A Heatlh-care medicinal liquor capable of lowering blood pressure |
| 05/07/2008 | CN101172141A Drug for curing coronary disease |
| 05/07/2008 | CN101172112A Compound with special property, composition containing the compound, preparing method and uses of the same |
| 05/07/2008 | CN101172111A Application of sterides in preparing medicament for treating cardiovascular and cerebrovascular diseases |
| 05/07/2008 | CN101171973A Application of gingili in preparing functional foods and medicines for preventing arteriosclerosis |
| 05/07/2008 | CN101171949A Health-care cold tea |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386341C Polypeptide of extracellular domain of sodium pump and use in preparation of drugs for adjusting the activity of sodium pump |
| 05/07/2008 | CN100386339C Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/07/2008 | CN100386338C Monkshood aglycone and homolog, Preparing method thereof and medicinal composition using said compound as active substance |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/07/2008 | CN100386316C Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/07/2008 | CN100386112C Arrhythmia treating Chinese medicine preparation and its preparation process |
| 05/07/2008 | CN100386094C Oral medicine for cardio-cerebral blood vessel diseases and its making method |
| 05/07/2008 | CN100386078C Nimodipine emulsion injection liquid and method for preparing the same |
| 05/07/2008 | CN100386076C Cardiovascular pharmaceutical formulation preparation method and uses |